Insider

Edwards Lifesciences Corp

EW Health Care · No analyses yet

1 insider sale recorded.

Mentioned in recent filings: Tariffs

What changed

No articles about this company yet. Follow it to hear when the first one appears.

Sector peers

How this company compares with 36 covered companies in Health Care (median revenue change +7.2% YoY), from archived SEC XBRL filings.

CompanyLatest revenueRevenue YoYOperating margin
Edwards Lifesciences Corp EW———
Unitedhealth Group Inc UNH$113B-0.4%5.8%
Mckesson Corp MCK$111B+7.6%1.4%
CVS Health Corp CVS$108B+5.4%3.3%
Cigna Group CI$73.7B+5.6%3.3%
Cardinal Health Inc CAH$67.5B+5.5%1.1%
Elevance Health, Inc. ELV$51.4B+1.4%2.5%

Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.

Insider trades

DatePersonTradeSharesAvg. priceValueFiling
October 8, 2026Daniel J. LippisSale 10b5-1 plan619$85.65$53,017SEC

All insider trades →

Large funds (13F)

FundSharesValueChange in sharesQuarter
BlackRock58,789,433$5,318,092,039+11.8%Q2 2026
State Street26,321,940$2,381,082,692+0.1%Q2 2026
Wellington Management16,827,967$1,522,257,896-23.5%Q2 2026
Geode Capital Management15,437,251$1,390,906,696+17.5%Q2 2026
Fidelity (FMR)8,435,949$763,115,873-41.8%Q2 2026
Norges Bank (Norway's sovereign fund)8,373,783$757,492,410—Q2 2026
Citadel Advisors3,997,925$361,652,295+670.3%Q2 2026
Millennium Management3,584,795$324,280,556+99.5%Q2 2026
Two Sigma Investments1,521,899$137,670,984+44.7%Q2 2026
Bridgewater Associates275,279$24,901,738+60.1%Q2 2026
Renaissance Technologies21,000$1,899,660-27.6%Q2 2026
T. Rowe Price2,857,608$258,500-30.1%Q2 2026

From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.